The European drug regulators are still investigating the reports of blood clots following vaccinations.
In a recent development, the health authorities in Denmark on Thursday said that they are temporarily suspending the use of the COVID-19 vaccine AstraZeneca as a precautionary measure after some patients developed blood clots since receiving the jab, including one who died.
Speaking to the media, the Danish Health Authority said, “The move comes following reports of serious cases of blood clots among people vaccinated with AstraZeneca’s Covid-19 vaccine.” But it cautiously added that “it has not been determined, at the time being, that there is a link between the vaccine and the blood clots”.
(Image source from: in.reuters.com)
Expert Panel Clears Oxford Vaccine In India:- The Expert Panel in the country made the vaccine for coronavirus available for the public and it issued an emergency use authorization for the vaccine that is developed by Oxford-AstraZeneca. The Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) paved paths for the mass immunization and the vaccination will begin in the next few days. The Indian government will administer the vaccine very soon. The recommendation on Covishield is forwarded to the Drugs Controller General of India (DGCI) and the final call will be taken soon.